Reimbursement issues with interferon therapies.
Huber
S L
SL
Division of Pharmacy, University of Texas M.D. Anderson Cancer Center, Houston 77030.
D003363:Cost Control; D005249:Fees and Charges; D006801:Humans; D007349:Insurance, Health, Reimbursement; D007372:Interferons / Q000627:therapeutic use*; D009369:Neoplasms / Q000191:economics / Q000628:therapy; D014481:United States; D014486:United States Food and Drug Administration
D007372:Interferons